Midlife Women's Health 2025: A Multi-Disciplinary Approach to Care
This is a virtual course
Midlife Women’s Health 2025 provides a multi-disciplinary approach to the care of menopausal women. Advances in research, technology, and pharmacology increase options available for midlife women, but this rapidly changing knowledge-base presents a challenge for clinicians. Care for women at this stage of life is optimized by education on a range of medical concerns provided by experts from a wide variety of medical specialties. Given demographic changes in the US population, midlife women are becoming an increasingly important group served by health care professionals, with needs that cross many areas of medical expertise.
In this educational activity, a multidisciplinary group of experts from Massachusetts General Hospital will present on the evaluation and management of osteoporosis, gastrointestinal malignancy, stress, obesity, substance use disorder, anxiety, sexual dysfunction, breast cancer, and menopausal hormone therapy to assist clinicians in caring for their midlife patients.
Target Audience
This activity is intended for physicians and advance practice nurses in primary care, gynecology, general surgery, internal medicine, endocrinology, psychiatry, gynecological oncology, cardiology, and preventive medicine who provide care to midlife women. Physicians and advance practice nurses in-training also are encouraged to attend.
Learning Objectives
Upon completion of this activity, participants will be able to:
- Assess midlife women for osteoporosis and utilize effective therapies.
- Identify risk factors for gastrointestinal malignancies to optimize screening strategies and outcomes.
- Integrate mind body strategies to reduce the adverse impact of stress on midlife women's health.
- Recognize the link between exercise, obesity and cardiovascular disease in women to improve health.
- Assess midlife women for alcohol and opioid use disorder and guide the use of available treatment options.
- Employ a greater understanding of anxiety in women to reduce disease burden.
- Integrate behavioral and pharmacologic strategies to improve sexual function in women.
- Formulate a strategy to identify women at increased risk of breast cancer to optimize care.
- Evaluate symptomatic midlife women for menopausal hormone therapy, incorporating an individualized assessment of risks and benefits.
Additional Information
Massachusetts General Hospital - Department of OB/GYN & Mass General Brigham
7:45am | Welcome & Introductory Remarks | Jan Shifren, MD |
8:00 | Osteoporosis: Treatment Options to Reduce Fracture Risk | Joy Tsai, MD |
8:35 | Q & A |
8:45 | Gastrointestinal Malignancy at Midlife: Risk Assessment & Screening Strategies | Daniel Chung, MD |
9:20 | Q & A |
9:30 | Stress Reduction at Midlife: A Mind Body Approach | John Denninger, MD, PhD |
10:05 | Q & A |
10:15 | Break |
10:30 | Battling the Bulge: Exercise, Weight & Cardiovascular Health at Midlife | James Sawalla Guseh, II, MD |
11:05 | Q & A |
11:15 | Alcohol & Opioid Use Disorder at Midlife: Optimizing Care | Sarah Wakeman, MD |
11:50 | Q & A |
12:00pm | Lunch Break |
1:00 | Anxiety in Midlife Women: Therapeutic Options | Noreen Reilly Harrington, PhD |
1:35 | Q & A |
1:45 | Sexual Dysfunction in Women: Causes & Care | Jan Shifren, MD |
2:20 | Q & A |
2:30 | Breast Cancer: Update on Screening Algorithms & Treatment Options | Francys Verdial, MD |
3:05 | Q & A |
3:15 | Break |
3:30 | Menopausal Hormone Therapy: Update for 2025 | Tara Iyer, MD |
4:05 | Q & A |
4:15 | Everything You Wanted to Know About Menopause, but Were Afraid to Ask | Isaac Schiff, MD; Katheryn Rexrode, MD, MPH & Linda Kelly, DNP, ANP-BC |
5:00pm | Adjourn |
Jan Shifren, MD - Course Director Dr. Shifren is a reproductive endocrinologist at the Massachusetts General Hospital and Director of the MGH Midlife Women’s Health Center. She focuses her research on menopause, including the effects of estrogens, androgens and alternative therapies on menopausal symptoms and sexual function. She is a past President of the Menopause Society. |
Isaac Schiff, MD Dr. Isaac Schiff is the Chief, Department of Obstetrics and Gynecology, Emeritus, at the Massachusetts General Hospital and the Joe Vincent Meigs Distinguished Professor of Gynecology at Harvard Medical School. He is Co-Director of the MGH Midlife Women’s Health Center. Dr. Schiff is an internationally known expert in menopause, a founding member of the Menopause Society, and the Editor-in-Chief of the journal, Menopause. |
Daniel Chung, MD Dr. Daniel Chung is a gastroenterologist at the Massachusetts General Hospital and Director of the High-Risk GI Cancer Clinic. He is also Medical Co-Director of the Center for Cancer Risk Assessment. His research aims to gain new insights into the molecular pathogenesis of GI malignancies, with a focus on colon cancer, angiogenesis, hereditary cancers, and genetic instability. |
John Denninger, MD, PhD Dr. John Denninger is a psychiatrist at the Massachusetts General Hospital and Director of Integrative Science and Clinical Training at the Benson-Henry Institute for Mind Body Medicine. His research focuses on how mind-body interventions can promote wellness and resilience. He also investigates how these interventions work by exploring genes, biochemistry, and brain activity. |
Tara Iyer, MD Dr. Tara Iyer is a family medicine and obesity specialist and Medical Director of the Menopause and Midlife Clinic in the Division of Women's Health at the Brigham and Women’s Hospital. Her clinical and research interests include weight management in women, bone health, and menopause care of the cancer survivor. |
Linda Kelly, DNP, ANP-BC Dr. Linda Kelly is an advanced practice provider at the Massachusetts General Hospital. She is the Nursing Director of the Midlife Women's Health Center in the Department of Obstetrics and Gynecology at MGH. |
Noreen Reilly Harrington, PhD Dr. Noreen Harrington is a psychologist at the Massachusetts General Hospital. She is an internationally-recognized expert in the cognitive-behavioral treatment of mood and anxiety disorders, with a special focus on bipolar disorder. |
Kathryn Rexrode, MD, MPH Dr. Kathryn Rexrode is an internist and Chief of the Division of Women's Health in the Department of Medicine at the Brigham and Women’s Hospital. She leads efforts to advance women’s health through research, clinical care, medical education and advocacy. He work focuses on metabolic factors, hormonal exposures and sex-specific risk factors for cardiovascular disease. |
James Sawalla Guseh, II, MD Dr. Sawalla Guseh is a cardiologist at the Massachusetts General Hospital and Director of the Cardiovascular Performance Program. His principal clinical interests include the treatment of patients, professionals, and athletes with varied forms of heart disease. His research focuses on understanding the molecular basis of human aerobic fitness. |
Joy Tsai, MD Dr. Joy Tsai is an endocrinologist and osteoporosis specialist in the Division of Endocrinology in the Department of Medicine at the Massachusetts General Hospital. Her research interests include optimizing postmenopausal osteoporosis therapy and bone health, with a focus on the evaluation of bone quality through advanced imaging techniques. |
Francys Verdial, MD Dr. Francys Verdial is a surgical oncologist at the Massachusetts General Hospital with special expertise in the management of breast cancer. |
Sarah Wakeman, MD Dr. Sarah Wakeman is the Medical Director for the Massachusetts General Hospital Substance Use Disorder Initiative and the Senior Medical Director for Substance Use Disorder at Mass General Brigham. Her research interests include evaluating models for integrated substance use disorder treatment in general medical settings, recovery coaching, physician attitudes and practice related to substance use disorder, and screening for substance use in primary care. |
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Mass General Brigham designates this live activity for a maximum of 7.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 7.75 AMA PRA Category 1 Credit™
- 7.75 Participation
Price
BEFORE MARCH 28, 2025
Registration Type | Tuition Fee |
---|---|
Physician | $270 |
Other Health Care Professionals & Physicians-in-Training | $125 |
AFTER MARCH 28, 2025
Registration Type | Tuition Fee |
---|---|
Physician | $295 |
Other Health Care Professionals & Physicians-in-Training | $150 |
Cancellation Policy:
Registrations cancelled on or before March 28, 2025 will be refunded, less a $35 administrative fee. Registrations cancelled after March 28, 2025 will not be refunded.
Contact mgbcpd@mgb.org if you require assistance in cancelling your online registration.
Please contact our Course Coordinator at MGHMidlifeCenter@mgh.harvard.edu prior to the event to assist you with any special needs.